Despite attaining a whole reaction with best induction therapy, minimal residual ailment frequently persists, necessitating consolidation therapy to mitigate the risk of relapse by eradicating residual condition. In patients which have acquired 7+3 induction therapy, consolidation therapy is initiated with significant-dose cytarabine, also known a